Abstract | OBJECTIVE: METHOD: Twenty-one children (mean age 8.2 years, range 5 through 14) participated in a 9-week open trial of fluoxetine in graduated doses (mean end dose 28.1 mg, range 10 to 60 mg) with systematic baseline and outcome evaluations and weekly clinical assessment. RESULTS: All 21 children met DSM-III-R and DSM-IV criteria for anxiety disorders. After fluoxetine treatment, 76% were improved, with diminished anxiety and increased speech in public settings, including school. Improvement at week 9 was inversely correlated with age. CONCLUSIONS:
|
Authors | E S Dummit 3rd, R G Klein, N K Tancer, B Asche, J Martin |
Journal | Journal of the American Academy of Child and Adolescent Psychiatry
(J Am Acad Child Adolesc Psychiatry)
Vol. 35
Issue 5
Pg. 615-21
(May 1996)
ISSN: 0890-8567 [Print] United States |
PMID | 8935208
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Serotonin Uptake Inhibitors
- Fluoxetine
|
Topics |
- Adolescent
- Child
- Child, Preschool
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluoxetine
(administration & dosage, adverse effects)
- Humans
- Male
- Mutism
(drug therapy, psychology)
- Personality Assessment
- Pilot Projects
- Selective Serotonin Reuptake Inhibitors
(administration & dosage, adverse effects)
- Treatment Outcome
|